IBMS Congress 2025
22 - 25 September 2025, Birmingham UK
Genetic Signatures are proud sponsors of IBMS Congress
Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development of real-time PCR based products for the routine detection of infectious diseases.
Our proprietary 3base® technology provides hospital and pathology laboratories with the ability to screen for a wide array of infectious pathogens with a high degree of specificity and reliability, in a rapid throughput (time to result) environment.
Visit our team to learn more about our unique diagnostic solutions at Booth #620 at the International Convention Centre (ICC), Birmingham.
Learn about our unique solutions for detecting gastrointestinal diseases
EasyScreen™ Pan-Enteric Pathogen Detection Kit targets:
Viruses
- Adenovirus 40/41
- Astrovirus
- Enterovirus
- Norovirus GI
- Norovirus GII
- Rotavirus A
- Sapovirus
Bacteria
- Aeromonas spp.
- Campylobacter spp.
- Clostridioides difficile (TcdA / TcdB)
- E.coli O157:H7 (z3276)
- ETEC (LT)
- ETEC (ST)
- EPEC (eaeA)
- Salmonella spp.
- Shigella spp.
- Enteroinvasive E.coli (EIEC)
- Vibrio cholerae
- Vibrio spp.
- Yersinia spp.
Parasites
- Giardia lamblia/intestinalis
- Entamoeba histolytica
- Cryptosporidium spp.
Shiga Toxin
- Shiga Toxin-1 (Stx1)
- Shiga Toxin-2 (Stx2)
The GS1 automated system
The GS1 provides medium and high throughput molecular solutions for diagnostics.
Benefits:
- Performs sample extraction and PCR setup
- Fast sample processing of up to 24 samples for the EasyScreen™ Pan-Enteric Pathogen Detection Kit
- 96-well PCR setup on one platform
- Significant walk-away-time and improved laboratory workflow
- Wizard-driven interface enables on-board sample and reagent traceability, and supports minimal wastage
- Small footprint allows improved use of space
Implementation of pan-enteric PCR screening at a UK general district hospital - benefits, pitfalls and lessons learnt
Presented by Elisabetta Savanco
Senior Biomedical Scientist in Medical Microbiology at Blackpool Teaching Hospitals NHS Foundation Trust
Gastroenteritis is a significant socioeconomic burden. It is crucial to identify or exclude infectious causes of gastroenteritis, as this informs treatment strategies and allow for effective management of hospital and public health resources.
Laboratories can play a key role in the diagnosis of infectious gastroenteritis, but traditional diagnostic testing for GI pathogens is notoriously inefficient. Blackpool Hospital has implemented pan-enteric PCR screening of all in-patient and community faecal samples, to improve management of GI infections.
This presentation will discuss the proven benefits of this change - such as improved outbreak management in hospital and care homes, better and quicker detection of notifiable diseases in the community, more efficient management of GI-related admissions and diagnosis of uncommon GI infections preventing their mismanagement - but also describe the pitfalls of pan-enteric PCR and the challenges of adapting infection prevention policies and patient pathways to maximise potential of this new testing strategy.
Elisabetta Savanco
Blackpool Teaching Hospitals NHS Foundation Trust
Elisabetta Savanco is an HCPC registered Senior Biomedical Scientist specialising in Medical Microbiology. Working in a general district hospital, her work focuses on tailoring diagnostic microbiology strategies to the needs of the local population.
Over the last 10 years, she has headed numerous service development initiatives, all aimed at reducing turnaround of microbiology investigations to optimise patient flows in the hospital setting.
In collaboration with local Gastroenterology services and the UK Health Security Agency, her recent efforts have focused on improving diagnosis and surveillance of gastrointestinal infections, through the introduction of enteric PCR screening for both primary and secondary care.
Other resources available on this topic
3-part webinar series featuring advances in molecular testing for gastrointestinal parasites
Access free on-demand webinars
White paper on Advances in Gastrointestinal Protozoa Testing: Molecular Ova and Parasite investigations
Download the white paper
Meet the team at IBMS Congress 2025
Allison Rossiter
Chief Executive Officer
John Buckels
Director, Sales & Support
EMEA
David Jacobs
Sales Manager
UK
Raj Bhagwati
Distributor Channel Manager
EMEA
Contact your local Genetic Signatures' representative
“Genetic Signatures’ assays offer our lab significant performance and quality improvements which allows clinicians to act on reliable, accurate, and timely results.”
Specialist Medical Scientist
Midlands Regional Hospital
Tullamore, Ireland
